Market Overview:
The global lactase market is expected to exhibit a growth rate (CAGR) of 6.1% during 2023-2028.
Lactase, also known as lactase-phlorizin hydrolase, is an enzyme naturally found in yeast, fungi and the small intestines of mammals, which hydrolyzes beta(β)-galactosides into simple sugar glucose and galactose. Its deficiency in the gut can lead to the development of lactose intolerance, which results in abdominal cramping and diarrhea after ingesting milk products. Consequently, lactase is added to regular milk for preventing the symptoms of lactose intolerance and enables individuals to consume adequate amounts of milk. Lactase is also available in different dosage forms, including drops, capsules and tablets.
A significant rise in the number of individuals suffering from lactose intolerance is positively influencing the demand for lactose-free dairy products. This represents one of the key factors positively influencing the lactase demand to produce lactose-free milk products. Moreover, the growing awareness about health and wellness among individuals is promoting the adoption of lactase pills, which are taken before consuming dairy products to help ease irritable bowel syndrome (IBS) symptoms. Apart from this, as liquid lactase has better functionality and high activity, it is finding extensive application in the pharmaceutical industry for manufacturing syrups and tonics. The leading market players are also introducing new delivery forms, such as strength caplets and fast-acting chewable tablets, to prevent lactose digestion problems like gas, nausea and stomachache. Furthermore, the growing awareness among individuals about healthy digestion and proper functioning of the immune system is anticipated to drive the market.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global lactase market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on source, form and application.
Breakup by Source:
Breakup by Form:
Breakup by Application:
- Food and Beverages
- Milk
- Cheese
- Yogurt
- Others
- Dietary Supplements
- Pharmaceuticals
Breakup by Region:
- North America
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Advanced Enzyme Technologies, Antozyme Biotech Pvt Ltd, Biolaxi Corporation, Chr. Hansen Holding A/S, Creative Enzymes, DuPont de Nemours Inc., Kerry Inc., Koninklijke DSM N.V., Merck KGaA, Novozymes A/S and Polttimo Oy.
Report Coverage:
Report Features |
Details |
Base Year of the Analysis |
2022 |
Historical Period |
2017-2022 |
Forecast Period |
2023-2028 |
Units |
US$ Billion |
Segment Coverage |
Source, Form, Application, Region |
Region Covered |
Asia Pacific, Europe, North America, Latin America, Middle East and Africa |
Countries Covered |
United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico |
Companies Covered |
Advanced Enzyme Technologies, Antozyme Biotech Pvt Ltd, Biolaxi Corporation, Chr. Hansen Holding A/S, Creative Enzymes, DuPont de Nemours Inc., Kerry Inc., Koninklijke DSM N.V., Merck KGaA, Novozymes A/S and Polttimo Oy |
Customization Scope |
10% Free Customization |
Report Price and Purchase Option |
Single User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499 |
Post-Sale Analyst Support |
10-12 Weeks |
Delivery Format |
PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |